RAC 11.1% $1.37 race oncology ltd

Race options thread, page-1018

  1. 2,750 Posts.
    lightbulb Created with Sketch. 3379
    It would be disappointing if there wasn't additional funding secured prior to '26 to pursue Zan+Inqovi in solid tumours.

    Funding isn't really a concern of mine and even less so once/if CPACS is validated in the next 12 months.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.